300 related articles for article (PubMed ID: 27421126)
1. [Lymphangioleiomyomatosis - new concepts on pathogenesis, diagnosis and treatment].
Sobiecka M
Wiad Lek; 2016; 69(2 Pt 1):123-9. PubMed ID: 27421126
[TBL] [Abstract][Full Text] [Related]
2. Lymphangioleiomyomatosis: new concepts in pathogenesis, diagnosis, and treatment.
Meraj R; Wikenheiser-Brokamp KA; Young LR; McCormack FX
Semin Respir Crit Care Med; 2012 Oct; 33(5):486-97. PubMed ID: 23001803
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases.
Young LR; Vandyke R; Gulleman PM; Inoue Y; Brown KK; Schmidt LS; Linehan WM; Hajjar F; Kinder BW; Trapnell BC; Bissler JJ; Franz DN; McCormack FX
Chest; 2010 Sep; 138(3):674-81. PubMed ID: 20382711
[TBL] [Abstract][Full Text] [Related]
4. Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer.
El-Chemaly S; Henske EP
Eur Respir Rev; 2014 Mar; 23(131):30-5. PubMed ID: 24591659
[TBL] [Abstract][Full Text] [Related]
5. [Pulmonary lymphangioleimyomatosis : review and case report].
Excoffier S; Guinand O; Rochat T
Rev Med Suisse; 2016 Aug; 12(527):1390-1393. PubMed ID: 28671794
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and Treatment Monitoring Potential of Serum Vascular Endothelial Growth Factor-D in Lymphangioleiomyomatosis.
Mou Y; Ye L; Wang J; Yee MS; Song YL; Zhu L; Jin ML
Lymphology; 2016 Sep; 49(3):140-9. PubMed ID: 29906075
[TBL] [Abstract][Full Text] [Related]
7. Correlation of serum vascular endothelial growth factor-D concentration with clinical presentation and course of lymphangioleiomyomatosis.
Radzikowska E; Jaguś P; Sobiecka M; Chorostowska-Wynimko J; Wiatr E; Kuś J; Roszkowski-Śliż K
Respir Med; 2015 Nov; 109(11):1469-75. PubMed ID: 26386638
[TBL] [Abstract][Full Text] [Related]
8. The role of vascular endothelial growth factor-D in diagnosis of lymphangioleiomyomatosis (LAM).
Xu KF; Zhang P; Tian X; Ma A; Li X; Zhou J; Zeng N; Gui YS; Guo Z; Feng R; Zhang W; Sun W; Cai B
Respir Med; 2013 Feb; 107(2):263-8. PubMed ID: 23127572
[TBL] [Abstract][Full Text] [Related]
9. Lymphangioleiomyomatosis.
Xu KF; Xu W; Liu S; Yu J; Tian X; Yang Y; Wang ST; Zhang W; Feng R; Zhang T
Semin Respir Crit Care Med; 2020 Apr; 41(2):256-268. PubMed ID: 32279296
[TBL] [Abstract][Full Text] [Related]
10. Emerging biomarkers of lymphangioleiomyomatosis.
Nijmeh J; El-Chemaly S; Henske EP
Expert Rev Respir Med; 2018 Feb; 12(2):95-102. PubMed ID: 29171770
[TBL] [Abstract][Full Text] [Related]
11. Concentration of Serum Vascular Endothelial Growth Factor (VEGF-D) and Its Correlation with Functional and Clinical Parameters in Patients with Lymphangioleiomyomatosis from a Brazilian Reference Center.
Amaral AF; de Oliveira MR; Dias OM; Arimura FE; Freitas CSG; Acencio MMP; de Alvarenga VA; Kairalla RA; Carvalho CRR; Baldi BG;
Lung; 2019 Apr; 197(2):139-146. PubMed ID: 30623243
[TBL] [Abstract][Full Text] [Related]
12. [Pulmonary lymphangioleiomyomatosis: From pathogenesis to management].
Chebib N; Khouatra C; Lazor R; Archer F; Leroux C; Gamondes D; Thivolet-Bejui F; Cordier JF; Cottin V
Rev Mal Respir; 2016 Oct; 33(8):718-734. PubMed ID: 26604019
[TBL] [Abstract][Full Text] [Related]
13. Lymphangioleiomyomatosis: a clinical update.
McCormack FX
Chest; 2008 Feb; 133(2):507-16. PubMed ID: 18252917
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analysis of lymphangioleiomyomatosis].
Gao P; Huang R; Cai BQ; Liu HR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):306-9. PubMed ID: 15266836
[TBL] [Abstract][Full Text] [Related]
15. Natural history of incidental sporadic and tuberous sclerosis complex associated lymphangioleiomyomatosis.
Di Marco F; Terraneo S; Dias OM; Imeri G; Centanni S; Rinaldo RF; Giuliani L; Lesma E; Palumbo G; Wanderley M; Ribeiro Carvalho CR; Guedes Baldi B
Respir Med; 2020 Jul; 168():105993. PubMed ID: 32469709
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.
Hirose M; Matsumuro A; Arai T; Sugimoto C; Akira M; Kitaichi M; Young LR; McCormack FX; Inoue Y
PLoS One; 2019; 14(2):e0212776. PubMed ID: 30818375
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary manifestations in tuberous sclerosis complex.
Gupta N; Henske EP
Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):326-337. PubMed ID: 30055039
[TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathological alterations of lymphangioleiomyomatosis in 14 Chinese patients.
Lu SH; Hou YY; Tan YS; Xu JF; Zeng HY; Sujie AK; Wang XD; Bai CX
Chin Med J (Engl); 2009 Aug; 122(16):1895-900. PubMed ID: 19781367
[TBL] [Abstract][Full Text] [Related]
19. Lymphangioleiomyomatosis: A review.
Hohman DW; Noghrehkar D; Ratnayake S
Eur J Intern Med; 2008 Jul; 19(5):319-24. PubMed ID: 18549932
[TBL] [Abstract][Full Text] [Related]
20. Lymphangioleiomyomatosis: differential diagnosis and optimal management.
Xu KF; Lo BH
Ther Clin Risk Manag; 2014; 10():691-700. PubMed ID: 25187723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
